PagerDuty, Inc.·4

Jul 20, 5:34 PM ET

Tejada Jennifer 4

4 · PagerDuty, Inc. · Filed Jul 20, 2026

Research Summary

AI-generated summary of this filing

Updated

PagerDuty (PD) Executive Chair Jennifer Tejada Sells ~399K Shares

What Happened

  • Jennifer Tejada, Executive Chair and Director of PagerDuty (PD), exercised/converted derivative awards and sold a total of 398,947 shares in mid‑July 2026. On July 16 she exercised 302,100 shares at $2.00 ($604,200) and sold those shares at a weighted average price of $10.70 for proceeds of $3,232,470. On July 17 she exercised/converted 96,847 shares at $2.00 ($193,694) and sold them at a weighted average price of $10.41 for proceeds of $1,008,468. Combined gross proceeds from the sales were $4,240,938; total pre‑tax exercise cost was $797,894 (net cash realized ≈ $3.44M).

Key Details

  • Transaction dates: July 16, 2026 (302,100 shares) and July 17, 2026 (96,847 shares).
  • Sale prices (weighted averages): $10.70 (range $10.50–$10.7001) and $10.41 (range $10.29–$10.74); per‑trade breakdowns available from filer on request (see footnotes).
  • Exercise price: $2.00 per share for both groups; filing also shows conversion lines at $0.00 reflecting conversion of derivative awards into common stock.
  • Footnotes: Trades were effected pursuant to a prearranged 10b5‑1 trading plan adopted Sept 10, 2025 (footnote F1). Footnote F2 notes a portion of the shares represent restricted stock units (RSUs).
  • Post‑transaction holdings: the filing does not state the insider’s remaining shares after these transactions.
  • Filing date: Form 4 filed July 20, 2026. (No late‑filing indication in the document.)

Context

  • This was an exercise/conversion of derivatives followed by immediate open‑market sales (i.e., a cash‑raising transaction rather than an outright open‑market purchase). Such “exercise then sell” transactions are commonly used to cover exercise costs, taxes or diversify, and are typically routine when done under a 10b5‑1 plan.
  • The presence of a 10b5‑1 plan and RSU conversions indicates these trades were pre‑arranged and/or tied to vested awards; they should not be read as a timing signal of management’s view beyond what the filer discloses.

Insider Transaction Report

Form 4
Period: 2026-07-16
Tejada Jennifer
DirectorExecutive Chair
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-07-16$2.00/sh+302,100$604,2001,980,351 total
  • Sale

    Common Stock

    [F1][F3][F2]
    2026-07-16$10.70/sh302,100$3,232,4701,678,251 total
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-07-17$2.00/sh+96,847$193,6941,775,098 total
  • Sale

    Common Stock

    [F1][F4][F2]
    2026-07-17$10.41/sh96,847$1,008,4681,678,251 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F5]
    2026-07-16302,10096,847 total
    Exercise: $2.00Exp: 2026-07-21Common Stock (302,100 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F5]
    2026-07-1796,8470 total
    Exercise: $2.00Exp: 2026-07-21Common Stock (96,847 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    171,870
  • Common Stock

    (indirect: By Trust)
    4,456
  • Common Stock

    (indirect: By Trust)
    4,456
  • Common Stock

    (indirect: By Trust)
    11,527
  • Common Stock

    (indirect: By Trust)
    11,527
  • Common Stock

    (indirect: By Trust)
    31,368
  • Common Stock

    (indirect: By Trust)
    31,368
Footnotes (5)
  • [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 10, 2025.
  • [F2]A portion of these shares represent restricted stock units.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.50 to $10.7001 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.29 to $10.74 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The option becomes exercisable as follows: (a) 50,000 of 250,000 shares become exercisable on the 7/22/2016 and an additional 50,000 shares subject to the incentive stock option first become exercisable on January 1 in each of 2017, 2018, 2019, and 2020; and (b) 3,638,426 shares first become exercisable on 7/22/2016, subject to our right to repurchase unvested shares in the event the reporting person's employment terminates. 12/48th of the part (b) shares vests on the 12-month anniversary of 7/18/2016 and 1/48th of the part (b) shares vests monthly thereafter for a total vesting period of 48 months.
Signature
/s/ Christopher Ferro, as Attorney-in-Fact for Jennifer Tejada|2026-07-20

Documents

1 file
  • 4
    wk-form4_1784583262.xmlPrimary

    FORM 4